Accueil » Communiqués de presse » Valbiotis announces the first visit of the first patientin the TOTUM•63 mode of action clinical study conducted by the INAF1, in partnership with Nestlé Health Science
Les communiqués de presse
28Apr2022
Valbiotis announces the first visit of the first patientin the TOTUM•63 mode of action clinical study conducted by the INAF1, in partnership with Nestlé Health Science
